Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05877118 · ClinicalTrials.gov registry record · NA

Improving Availability of Intranasal Naloxone

A NA study of Opioid Overdose, sponsored by Hartford Hospital.

Recruiting
Registry status
NA
Development phase
84
Enrollment target
2
Study locations

NCT05877118 is a NA study of Opioid Overdose that is actively recruiting participants, run by Hartford Hospital. The registered enrollment target is 84 participants, below the 4,232-participant average among 8 other Opioid Overdose trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05877118, a NA study of Opioid Overdose, is actively recruiting participants, sponsored by Hartford Hospital.

RECRUITING
Registry status
NA
Development phase
84 participants
Enrollment target
2
Study locations

Study Summary

While there is a lifesaving medication called naloxone that can reverse the deadly effects of opioid overdose, patients often fail to fill the prescription at the pharmacy when it is prescribed. This is particularly concerning and true in those at the highest risk of death-those who end up in the emergency department for opioid overdose. The goal of this study is to compare the impact of different overdose education on naloxone prescription fill rates in opioid users being discharged from our hospital emergency department. You will receive either (a) written education about naloxone through their MyChart account, or (b) a concise one-page handout and 4-minute video clip reviewed with the participant and a support individual (family/friend) prior to discharge.

Conditions Studied

Opioid Overdose

Interventions

  • BEHAVIORAL Enhanced Overdose Education (EOE)
  • BEHAVIORAL Standard education

Study Locations (2)

Connecticut

  • Hartford Hospital Emergency Department - Hartford
  • Olin Neuropsychiatry Research Center - Hartford

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2024-03-01
Est. Completion 2025-12-31
Phase NA

Sponsor

Hartford Hospital

75 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05877118

The ClinicalTrials.gov registry entry for NCT05877118 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,232-participant average among 8 other Opioid Overdose trials with a reported enrollment target (98% lower). The listed sponsor is Hartford Hospital, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Overdose appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Overdose Education (EOE) is the first listed.

NCT05877118 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT05877118 about?

NCT05877118 is a clinical study titled "Improving Availability of Intranasal Naloxone". While there is a lifesaving medication called naloxone that can reverse the deadly effects of opioid overdose, patients often fail to fill the prescription at the pharmacy when it is prescribed. This is particularly concerning and true in those at the highest risk of death-those who end up in the em...

What is the current status of trial NCT05877118?

This trial is currently recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2024-03-01. Estimated completion is 2025-12-31.

What conditions does trial NCT05877118 study?

This clinical trial studies the following conditions: Opioid Overdose.

What interventions are being tested in trial NCT05877118?

The interventions under investigation include: Enhanced Overdose Education (EOE) (BEHAVIORAL), Standard education (BEHAVIORAL).

Who is sponsoring clinical trial NCT05877118?

This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05877118 being conducted?

This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Overdose

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Overdose

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.